| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $114.2M | +631.8% |
| Cost of Revenue | $258.0M | +161.0% |
| Gross Profit | -$143.8M | -72.8% |
| R&D Expense | $28.5M | +25.4% |
| SG&A Expense | $85.1M | +41.7% |
| Operating Income | -$259.3M | -48.0% |
| Pre-tax Income | -$969.6M | -41.4% |
| Income Tax | $24K | +14.3% |
| Net Income | -$969.6M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $568.0M | +664.5% |
| Accounts Receivable | $6.8M | +123.1% |
| Inventory | $59.0M | +79.8% |
| Current Assets | $708.5M | +293.8% |
| Total Assets | $885.2M | +240.0% |
| Current Liabilities | $143.5M | +120.9% |
| Long-term Debt | $813.3M | +156.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$211.2M | -37.2% |
| Capital Expenditures | $53.8M | +62.2% |
| Investing Cash Flow | -$54.7M | -64.8% |
| Financing Cash Flow | $787.1M | +282.4% |
| Free Cash Flow | -$265.0M | -41.6% |
| -41.4% |
| EPS (Basic) | -$6.69 | -47.0% |
| EPS (Diluted) | -$6.69 | -47.0% |
| Total Liabilities |
| $1.76B |
| +109.3% |
| Stockholders' Equity | -$2.24B | -109.1% |